Vericred, Inc., launched a transparency tool for prescription drugs to help people more effectively manage their pharmaceutical benefit plans. Jane is quoted in the press release, saying, “With patients bearing more out-of-pocket costs for prescription drugs, the new personal health economics are compelling patients to become informed health consumers. These consumers need transparent, easy-to-use, helpful information on the price of prescription drugs and therapeutic alternatives.”
Jane quoted in Vericred press release on health consumers and prescription drugs
By Jane Sarasohn-Kahn on 18 May 2016 in
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global health care enterprise.
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance. Click onto the Pfizer Value of Vaccines site and you can watch four episodes covering the challenges with adult vaccination, the employer and health plan member's journey to vaccination, reimbursement, and collaborating for proactive prevention.
Jane will be working with EU- and UK-based clients in September and October 2026, collaborating with stakeholders in digital health, public/community health, retail health, and growing opportunities for health-at-home. Stay tuned to her updates here on Health Populi on-the-ground as she lives the digital nomadic work-life in Italy, Belgium, the Netherlands, and in London.